Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Taiwan Biotech Delegation Heads to BIO 2026 to Advance Global Partnerships and Innovation


News provided by

BPIPO

Jun 22, 2026, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Taiwan pavilion to present 40+ technologies from 33 companies at the world's largest biotechnology convention

SAN DIEGO, June 22, 2026 /PRNewswire/ -- Taiwan is showcasing the strength of its biotechnology ecosystem at BIO International Convention 2026 in San Diego from June 22–25, bringing together 33 biotechnology companies and more than 40 innovative technologies as it seeks to deepen global partnerships, attract investment and reinforce its position as one of Asia's leading biotechnology hubs.

Continue Reading
Networking with Taiwan: A Premier Biotech Partner in Asia
Networking with Taiwan: A Premier Biotech Partner in Asia

Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and supported by Taiwan's Ministry of Economic Affairs and other government agencies, the Taiwanese delegation will feature advancements spanning drug development, precision medicine, Contract Development and Manufacturing Organization (CDMO) services, biomanufacturing and digital health at the Taiwan Pavilion (Booth #2621).

Guided by the theme "Taiwan, Your Best Partner in Asia," Taiwan is building on the strong engagement and partnerships forged at BIO 2025 and leveraging BIO 2026 as a launchpad to showcase its thriving innovation ecosystem, deepen strategic collaborations, and unlock new opportunities in licensing, co-development, manufacturing collaboration and investment.

Taiwan at BIO 2026: Key Events & Engagement Opportunities

  • BIO Session (June 22,1:45-2:45 PM, Room 29AB)
    Bringing together experts from Taiwan, the United States, Singapore, Japan, and South Korea, the session will explore the future of chronic disease management and examine the healthcare economic value of Health Technology Assessment (HTA) from both technology and payer perspectives.

  • Start-Up Stadium (June 22, 4:50-5:00 PM, Room 5B)
    Spotlight on Vacino Biotech, showcasing next-generation biotechnology innovations.

  • Global Innovation Hub (June 23, 2:30-2:45 PM, Room 5A)
    Exploring Taiwan's biotech ecosystem and partnership opportunities, fueled by a thriving startup landscape and dynamic capital markets that continue to achieve record highs in market valuation and fundraising.

  • Taiwan Happy Hour Networking Reception (June 23, 4:00-5:00 PM, Taiwan Pavilion)
    An open networking session with more than 200 biotech leaders, investors, and global partners.

Taiwan's Biotech Industry Surpasses NT$1 Trillion in Market Value Amid IPO Boom

Taiwan's presence at BIO 2026 reflects the strength of its rapidly growing biotechnology sector. According to the 2025 Biotechnology Industry in Taiwan white paper, the industry generated a record NT$775.4 billion (US$25 billion) in revenue in 2024 and comprised 147 listed and over-the-counter biotech companies with a combined market value exceeding NT$1.47 trillion, underscoring Taiwan's position as one of Asia's leading biotechnology hubs.

"BIO 2026 offers an important opportunity for Taiwan's biotech industry to demonstrate its manufacturing capabilities, connect with global partners and explore new avenues for collaboration," said Michael Huang, Director of BPIPO. "We look forward to advancing healthcare innovation together with industry stakeholders worldwide."

As BIO 2026 brings together biotechnology leaders, investors, and industry stakeholders from around the world, Taiwan's participation provides an important platform for deepening international partnerships and accelerating cross-border collaboration. By showcasing its manufacturing capabilities, commercial-ready technologies and partnership opportunities, Taiwan aims to support the development of new technology partnerships, licensing agreements and clinical collaborations, while advancing its role in the global healthcare and life sciences ecosystem.

About BPIPO

The Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) supports the growth and internationalization of Taiwan's biomedical sector by fostering innovation, industry collaboration and global partnerships. For more information, please visit BPIPO's website.

View the BravoTaiwan delegation list or discover more at www.bravotaiwan.cc

Domain

Company Name

Company Introduction

Biologics

AcadeMab Biomedical

Transforming Cancer Care & Next-Generation Vaccines

ACRO Biomedical

Make the impossible POSSIBLE.

Animmune Biotechnology

Rooted in Heritage, Rising in Innovation: Defining the Future of Animal Health.

PharmaEssentia

A fully-integrated biopharmaceutical company developing best-in-class therapies.

PlasmonicTron

PlasmonicTron standardizes large human 3D organoid production for industrial NAMs.

Taiwan Universe BioMedicine

Taiwan's biotech innovator pioneering next-gen vaccines for global health.

Biotech

Acer

Breaking barriers between people and technology.

Bened Biomedical

Fulfill the unmet neurological voids with novel neurobiotics

Coherence Biotech

Continuous lab automation for trusted multi-day cell and organoid experiments.

Ever Supreme Bio Technology

Pioneering cell therapy breakthroughs to improve health and quality of life worldwide.

Far East Bio-Tec.

Far East Bio-Tec develops microalgae derived APIs, antivirals, and drug delivery nanocarrier.

Health Ever Bio-Tech

HEB is a biotech company specializing in the R&D of new drugs for urological disorders.

Leadgene Biosolutions

Patented 96/24-well mixing and real-time DO, pH, OCR & ECAR monitoring for cell culture.

NanoRay Biotech

NanoRay Biotech develops new-generation X-ray tubes for medical imaging and tumor therapy.

OBI Pharma

OBI Pharma advances precision medicine with next-generation ADCs powered by Obrion®.

Precisemab Biotech

Precisemab develops Antibody Lock technology for safer, disease-site antibody activation.

TAHO Pharma

Innovating Drug Delivery for Better Patient Outcomes.

TCM Biotech International

We care about women's health and are developing a promising new drug for recurrent UTI.

TLC BioSciences

Lipid nanoparticle technology platform company advancing pain (Ph3), GLP-1, and CAR-T programs.

Vacino Biotech

The best brain delivery company.

CDMO

/ Contracted Service

Pharmigene

Pioneer precision medicine through advanced diagnostic solutions and patented pharmacogenomic tests.

SCIWIN Laboratories

SciWin Laboratories provides custom synthesis, CRO, CMO, and CDMO services.

Simpson Biotech

A biofermentation company for natural ingredients & recombinant proteins OEM.

Taiwan Bio-Manufacturing

A pure-play CRDMO providing GMP solutions for mRNA, cell therapy, viral vectors & complex biologics.

Taiwan Contract Research One-Stop Service

T.CROSS: Innovating Forward, Building a New Preclinical Service Ecosystem in Taiwan.

Yung Shin Pharm. Ind.

20+ years of FDA/PMDA compliance, delivering premium CMO/CDMO pharmaceutical services worldwide.

Medical Device

BloodScan Biotech

Building the blood test for every cancer visit!

Precision Health

AB DigiHealth

Achieving IVF success through innovation and science.

Anivance AI

Anivance AI builds human validation infrastructure for AI-driven drug development.

CancerFree Biotech

Biotech Organoid intelligence platform: patient-derived tumor models and AI-automated lab workflows.

Instant NanoBiosensors

Instant NanoBiosensors (INB) provides protein biomarker platforms and integrated NGS solutions.

Small Molecule Drug

AnnJi Pharmaceutical

AnnJi is a clinical-stage NCE drug developer for neglected neuro, derma and rare diseases

Dasher Neuroscience

Dasher Neuroscience, a late-clinical-stage biotech, uses AI to accelerate CNS therapies.

Gilva Therapeutics

Gilva is aimed to be a worldwide novel small molecule drug provider.

SOURCE BPIPO

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.